Earl J. Beadle Productions, Inc. Stem cells have the potential to treat a wide range of diseases, but developing those cures is a process that has many hurdles. Dr. Hans Keirstead has a CIRM grant to ...

A major challenge in developing stem cell-based cures for disease is maturing those cells into adult cell types that can be used for transplantation or to study human disease. Dr. Mark Mercola has a ...

Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is the former president and CEO of Novocell (now ViaCyte), a La ...

The simple term “stem cell” actually refers to many different types of cells. The tissue-specific stem cells, or adult stem cells, replenish tissues throughout our lives. Embryonic stem cells exist ...

Le réservoir du VIH reste un obstacle difficile à surmonter pour parvenir à un remède thérapeutique contre le VIH. Plusieurs stratégies ont été développées pour purger le réservoir, notamment ...

β-地中海贫血是一种由 β-珠蛋白基因的多种突变引起的遗传性疾病，可导致红细胞 (RBC) 发育严重减少。输血依赖性β-地中海贫血未得到满足的医疗需求是巨大的，尽管采用了慢性输血和铁螯合疗法的标准护理治疗，但预期寿命仅为约30-50岁。铁超负荷引起的心肌 ...

A pesar de lo prometedoras que son las células madre para la medicina regenerativa, la eficacia de las terapias basadas en células madre está muy limitada por un deficiente injerto y supervivencia de ...

Otras instituciones de California están estableciendo sus propios programas. Vuelva a consultar aquí para obtener actualizaciones sobre los lugares de capacitación. Enviar recursos sobre células madre ...

镰状细胞病是一种表现多变的严重疾病。唯一的治疗方法是同种异体干细胞移植，最好是使用 HLA 相同的同胞供体。然而，<20% 的镰状细胞病患者有这样的捐赠者。 招募一名患者来填补试点研究的剩余空缺，并招募患者继续进行第二阶段研究。 在加州基地开发和 ...

Bourse de formation à la recherche Ville de l'espoir, Institut de recherche Beckman Programme de formation à la recherche en biologie des cellules souches et en médecine régénérative $5,234,731 ...

L’injection in utero in vivo et l’électroporation du néocortex embryonnaire de souris constituent un outil puissant pour la manipulation des progéniteurs individuels tapissant les parois du ventricule ...

Anne-Marrie Duliege, MD, is a Senior Executive and Chief Medical Officer with 30 years of experience guiding biopharmaceutical companies through development and commercial stages. Dr. Duliege is ...